HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photoaccentuated erythroderma associated with CD4+ T lymphocytopenia: successful treatment with 5-methoxypsoralen and UVA, interferon alfa-2b, and extracorporeal photopheresis.

Abstract
We describe a 53-year-old HIV-negative white man who had chronic CD4+ T lymphocytopenia and photoaccentuated erythroderma with lymphoma-like histologic changes. The erythroderma completely responded to 5-methoxypsoralen and UVA (PUVA), interferon alfa-2b, and extracorporeal photopheresis. During therapy opportunistic skin infections, including tinea corporis, warts, and disseminated molluscum contagiosum, developed. Although the patient met the current definition of idiopathic CD4+ T lymphocytopenia (ICTL), we cannot rule out the possibility that this peripheral CD4+ T lymphocytopenia resulted from sequestration of CD4+ T lymphocytes in erythrodermic skin.
AuthorsP Wolf, R Müllegger, L Cerroni, R Aigner, G Fueger, G Höfler, J Derbaschnig, H Kerl
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 35 Issue 2 Pt 2 Pg. 291-4 (Aug 1996) ISSN: 0190-9622 [Print] United States
PMID8698908 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • 5-Methoxypsoralen
  • Methoxsalen
Topics
  • 5-Methoxypsoralen
  • Dermatitis, Exfoliative (drug therapy, pathology)
  • HIV Seronegativity
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Lymphoma, T-Cell, Cutaneous (pathology)
  • Male
  • Methoxsalen (analogs & derivatives, therapeutic use)
  • Middle Aged
  • Molluscum Contagiosum (etiology)
  • Opportunistic Infections (etiology)
  • PUVA Therapy
  • Photopheresis
  • Photosensitivity Disorders (drug therapy, pathology)
  • Recombinant Proteins
  • Skin Neoplasms (pathology)
  • T-Lymphocytopenia, Idiopathic CD4-Positive (drug therapy, pathology)
  • Tinea (etiology)
  • Warts (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: